10x Genomics TXG paid Tarplin, Downs & Young $40K for lobbying in Q4 2023 · Health Issues

Trade details

Type: Lobbying report
Amount: $40,000
Quarter: Q4 2023
Stock: 10x Genomics TXG
Client: 10X Genomics
Reported: 24/01/20

Down 50.0% from last quarter

What else happened in 10x Genomics around then

Filed or reported within 30 days of the trade day · 23/12/01~24/01/30

10X Genomics's other lobbying reports

10X Genomics
Lobbying10x Genomics
Lobbying
10x Genomics
TXG
$80K
$80K
Reported 23/10/17
for Q3 2023
10X Genomics
Lobbying10x Genomics
Lobbying
10x Genomics
TXG
$80K
$80K
Reported 23/07/17
for Q2 2023
10X Genomics
Lobbying10x Genomics
Lobbying
10x Genomics
TXG
$80K
$80K
Reported 23/04/18
for Q1 2023
10X Genomics
Lobbying10x Genomics
Lobbying
10x Genomics
TXG
$80K
$80K
Reported 23/01/20
for Q4 2022

10x Genomics TXG paid Tarplin, Downs & Young $40K for lobbying in Q4 2023 · Health Issues | Whalegun